Digital pelvic health Axena Health offers the Leva Pelvic Health System as a digitally-enabled prescription therapeutic solution, indicating strong potential for expansion through clinician partnerships, telemedicine channels, and digital health distributors seeking at-home treatment options for pelvic floor disorders.

Women-led focus A women-led company focused on pelvic floor disorders positions Axena Health as a specialized partner for women’s health networks, OBGYN practices, and women’s health advocacy groups, suggesting opportunities for targeted outreach to clinicians and patient communities seeking evidence-based, patient-centric solutions.

Clinical evidence The Leva system is supported by published clinical evidence and peer-reviewed research, creating sales opportunities with hospital systems, payer programs, and clinical decision support teams that prioritize proven, study-backed pelvic health therapeutics.

Prescription channel Since Leva is available by prescription only, there is a clear pathway to engage with healthcare providers, specialty clinics, and telehealth platforms to embed this device as a standard of care for eligible patients, expanding referral networks and reimbursement conversations.

SMB focus with growth potential With 51-200 employees and revenue in the low to mid six figures to low millions, Axena Health sits near the growth sweet spot for strategic partnerships with mid-market medtech distributors, digital health integrators, and value-based care initiatives looking to add pelvic health offerings to their portfolios.